Skip to main content
Data in Brief logoLink to Data in Brief
. 2016 Apr 29;7:1570–1575. doi: 10.1016/j.dib.2016.04.055

Dataset of mitochondrial genome variants associated with asymptomatic atherosclerosis

Margarita A Sazonova a,b, Andrey V Zhelankin b, Valeria A Barinova b, Vasily V Sinyov b, Zukhra B Khasanova b, Anton Y Postnov b, Igor A Sobenin a,b, Yuri V Bobryshev a,c,, Alexander N Orekhov a,d,e
PMCID: PMC4865666  PMID: 27222855

Abstract

This dataset report is dedicated to mitochondrial genome variants associated with asymptomatic atherosclerosis. These data were obtained using the method of next generation pyrosequencing (NGPS). The whole mitochondrial genome of the sample of patients from the Moscow region was analyzed. In this article the dataset including anthropometric, biochemical and clinical parameters along with detected mtDNA variants in patients with carotid atherosclerosis and healthy individuals was presented. Among 58 of the most common homoplasmic mtDNA variants found in the observed sample, 7 variants occurred more often in patients with atherosclerosis and 16 variants occurred more often in healthy individuals.

Keywords: mtDNA variant, Mitochondrial genome, Homoplasmic, Asymptomatic atherosclerosis


Specifications table

Subject area Genetics, Molecular genetics
More specific subject area Atherosclerosis
Type of data Sequencing data
How data was acquired Roche 454 GS Junior Titanium
Data format Raw, analysed
Experimental factors Ultrasound scanning of carotid arteries; extraction of DNA from blood leucocytes of patients; enrichment of mitochondrial genome by the amplification of whole mitochondrial genome; sequencing of mtDNA
Experimental features We performed next generation pyrosequencing of whole mitochondrial genome of the sample of patients from the Moscow region with carotid atherosclerosis and control subjects without atherosclerosis. mtDNA variants were characterized by the occurrence in the compared groups.
Data source location Moscow, Russian Federation
Data accessibility Data is with this article.

Value of the data

  • The data of next generation pyrosequencing of whole mitochondrial genome let us find homoplasmic variants associated with atherosclerotic lesions of carotid arteries in patients from the Moscow region with atherosclerosis and subjects without atherosclerotic lesions of carotid arteries.

  • mtDNA sequencing data was obtained using Roche 454 GS Junior Titanium system.

  • The data of statistical analysis was obtained using IBM SPSS Statistics v.21.0.

  • The data helps to detect new genetic markers of individual predisposition to asymptomatic atherosclerosis in humans.

1. Data

The relevant data is provided in this article. See Table 1 and Table 1, and Fig. 1, Fig. 2. The raw data files (fastq files) that were used in the analysis and interpretation are available in Institute for Atherosclerosis Research, Skolkovo Innovative Center, Moscow Region, Russian Federation. http://inat.ru/.

Table 1.

The most common homoplasmic mtDNA variants in the observed sample.

mtDNA variant Gene/region Character of mutationa % of cases
General Controls Atherosclerotic patients
m.73A>G Noncoding 51.5 51.6 51.4
m.146T>C Noncoding 7.4 6.5 8.1
m.152T>C Noncoding 14.7 19.4 10.8
m.185G>A Noncoding 5.9 6.5 5.4
m.195T>C Noncoding 14.7 22.6 8.1
m.204T>C Noncoding 5.9 3.2 8.1
m.228G>A Noncoding 5.9 3.2 8.1
m.263A>G Noncoding 91.2 87.1 94.6
m.489T>C Noncoding 7.4 6.5 8.1
m.709G>A RNR1 14.7 19.4 10.8
m.750A>G RNR1 86.8 83.9 89.2
m.930G>A RNR1 7.4 6.5 8.1
m.1438A>G RNR1 83.8 83.9 83.8
m.1719G>A RNR2 5.9 0.0 10.8
m.1811A>G RNR2 13.2 12.9 13.5
m.1888G>A RNR2 11.8 12.9 10.8
m.2706A>G RNR2 50.0 45.2 54.1
m.3010G>A RNR2 20.6 16.1 24.3
m.3107delN RNR2 89.7 83.9 94.6
m.4216T>C ND1 m 20.6 22.6 18.9
m.4769A>G ND2 s 85.3 77.4 91.9
m.4917A>G ND2 m 14.7 16.1 13.5
m.5147G>A ND2 s 8.8 9.7 8.1
m.7028C>T COX1 s 48.5 48.4 48.6
m.8251G>A COX2 s 7.4 3.2 10.8
m.8697G>A ATP6 s 13.2 16.1 10.8
m.8860A>G ATP6 m 92.6 90.3 94.6
m.10398A>G ND3 m 16.2 19.4 13.5
m.10463T>C TRNR 14.7 16.1 13.5
m.11251A>G ND4 s 19.1 22.6 16.2
m.11467A>G ND4 s 19.1 19.4 18.9
m.11719G>A ND4 s 50.0 51.6 48.6
m.11812A>G ND4 s 10.3 9.7 10.8
m.12308A>G TRNL2 20.6 22.6 18.9
m.12372G>A ND5 s 20.6 22.6 18.9
m.12612A>G ND5 s 8.8 9.7 8.1
m.12705C>T ND5 s 5.9 3.2 8.1
m.13368G>A ND5 s 14.7 16.1 13.5
m.13708G>A ND5 m 11.8 16.1 8.1
m.14233A>G ND6 s 11.8 9.7 13.5
m.14766C>T CYTB m 45.6 48.4 43.2
m.14798T>C CYTB m 8.8 12.9 5.4
m.14905G>A CYTB s 14.7 16.1 13.5
m.15326A>G CYTB m 89.7 87.1 91.9
m.15452C>A CYTB m 22.1 25.8 18.9
m.15607A>G CYTB s 11.8 12.9 10.8
m.15784T>C CYTB s 4.4 9.7 0.0
m.15928G>A TRNT 11.8 12.9 10.8
m.16069C>T Noncoding 10.3 12.9 8.1
m.16126T>C Noncoding 23.5 29.0 18.9
m.16145G>A Noncoding 5.9 6.5 5.4
m.16223C>T Noncoding 7.4 3.2 10.8
m.16256C>T Noncoding 7.4 12.9 2.7
m.16294C>T Noncoding 14.7 19.4 10.8
m.16296C>T Noncoding 8.8 9.7 8.1
m.16304T>C Noncoding 11.8 9.7 13.5
m.16311T>C Noncoding 10.3 6.5 13.5
m.16519T>C Noncoding 51.5 51.6 51.4
a

For mutations in protein coding genes: m – missense, s – synonymous.

Fig. 1.

Fig. 1.

The most common mtDNA variants that were more frequent (with ratio >=1.5) in controls compared with atherosclerotic patients. For positions in coding region, names of genes are given in brackets.

Fig. 2.

Fig. 2.

The most common mtDNA variants that were more frequent (with ratio >=1.5) in atherosclerotic patients compared with controls. For positions in coding region, names of genes are given in brackets.

2. Experimental design, materials and methods

This dataset report is dedicated to mtDNA variants, associated with asymptomatic atherosclerosis. These data were obtained using the method of next generation pyrosequencing (NGPS). The whole mitochondrial genome of the sample of patients from the Moscow region was analyzed.

In this article the dataset of homoplasmic mtDNA variants in patients with atherosclerosis and healthy individuals from the Moscow region was presented (Table 1 and Table 1, Fig. 1, Fig. 2).

2.1. Materials

The materials for obtaining the data were leukocytes from whole blood of 68 patients. 31 subjects with carotid atherosclerosis and 37 control subjects without atherosclerosis were selected for the study [1], [2], [3], [4], [5] (Table 1).

Selected individuals did not have severe clinical manifestations of atherosclerosis and oncological diseases. The number of patients with diabetes mellitus was minimized (3 subjects among the sample).

2.2. Methods

To assess the state of the carotid artery wall, high-resolution B-mode ultrasonography was performed with ultrasound scanner SonoScape SSI-1000 (China) using a linear vascular 7.5 MHz sensor. Values of the average carotid intima-medial thickness (CIMT) were used to estimate the presence and severity of atherosclerotic plaques in carotid arteries (Table 1). Borderline age-related CIMT values for Moscow region population were used to characterize the presence of carotid atherosclerosis [6]. If there was a presence of atherosclerotic plaque with the carotid artery stenosis of more than 20% or thickening of the intima-media layer exceeding the boundaries of the 75th percentile, as well as the combination of these factors, persons were considered as belonging to the group of patients with atherosclerosis. Controls were characterized by CIMT values that does not exceed median values for appropriate age group, and by the absence of atherosclerotic plaques (for some persons – the presence of carotid stenosis that does not exceed 20%).

The extraction of DNA from blood leukocytes of patients was performed using methods developed earlier by us [7], [8], [9], on the basis of the methods, published by Maniatis et al. [10], [11]. Before sequencing, an enrichment of mitochondrial genome by the amplification of the whole mitochondrial genome using REPLI-g Mitochondrial Kit (Qiagen, Germany) was performed. To carry out mtDNA sequencing, Roche 454 GS Junior Titanium system (Roche Applied Science, USA) was used. Sequencing workflow was performed according to the manufacturer׳s recommendations and using appropriate instruments and reagents.

Sequence analysis of mitochondrial DNA was carried out using GS Reference Mapper software (Roche Applied Science, USA). Cambridge reference sequence of the human mitochondrial genome (rCRS, NC_012920.1) was used for mapping [12]. Statistical analysis of the obtained data was carried out using IBM SPSS Statistics v.21.0.

2.3. Data obtained with the use of NGPS

We identified 58 most common homoplasmic variants that were characterized by more than 5% presence in the observed sample (Table 1). Among them, 7 mtDNA variants were associated with presence of atherosclerotic lesions of carotid arteries (204C, 228A, 1719A, 3010A, 8251A, 12705T, 16223T) (Fig. 1) and 16 variants mtDNA occurred more often in healthy individuals (152T, 195C, 263A, 709A, 750A, 4769A, 8697A, 8860A, 13708A, 14798C, 15326A, 15784С, 16069T, 16126C, 16256T, 16294T) (Fig. 2).

Acknowledgments

This study was supported by the Russian Scientific Foundation, grant # 15-15-10022.

Footnotes

Appendix A

Supplementary data associated with this article can be found in the online version at doi:10.1016/j.dib.2016.04.055.

Appendix A. Supplementary material

Supplementary material

mmc1.doc (24.1KB, doc)

Supplementary material Table 1. Available data about subjects used in the study.

mmc2.xlsx (48.4KB, xlsx)

References

  • 1.Miasoedova V.A., Kirichenko T.V., Orekhova V.A., Sobenin I.A., Mukhamedova N.M., Martirosian D.M., Karagodin V.P., Orekhov A.N. Study of intima-medial thickness (IMT) of the carotid arteries as an indicator of natural atherosclerosis progress in Moscow population. Patol. Fiziol. Eksp. Ter. 2012;3:104–108. [PubMed] [Google Scholar]
  • 2.Aladinsky V.A., Nikiforov N.G., Orekhova V.A., Melnichenko A.A., Karagodin V.P., Sobenin I.A., Orekhov A.N. Direct antiatherosclerotic therapy: possible approaches, results of clinical trials. Patol Fiziol Eksp Ter. 2013;4:76–83. [PubMed] [Google Scholar]
  • 3.Chernova E.V., Sobenin I.A., Melnichenko A.A., Karagodin A.P., Orekhov A.N. Serum atherogenicity as a pathogenetic target for direct anti-atherosclerotic therapy. Pathogenesis. 2013;11:28–41. [Google Scholar]
  • 4.Feoktistov A.S., Gavrilin M.A., Karagodin V.P., Bobryshev Y.V., Orekhov A.N. Promising therapeutic approaches to inhibition of atherogenic modification (desialylation) of low density lipoproteins. Pathogenesis. 2013;11:46–50. [Google Scholar]
  • 5.Temchenko A.V., Nikiforov N.G., Orekhova V.A., Melnichenko A.A., Karagodin V.H., Sobenin I.A., Orekhov A.N. Achievements in therapy of atherosclerosis. Pathogenesis. 2013;11:11–18. [Google Scholar]
  • 6.Sobenin I.A., Surnin S.A., Karagodin V.P., Myasoedova V.A., Kirichenko T.V., Chuprakova O.V. Variability of intima-media thickness of common carotid arteries index in the Moscow city population among persons without clinical manifestations of atherosclerosis. Ther. Arch. 2011;12:58–62. [PubMed] [Google Scholar]
  • 7.Sazonova M.A., Amosenko F.A., Kapranov N.I., Kalinin V.N. Molecular genetic analysis of TUB18 and TUB20 intragenic polymorphism and various mutations of the CFTR gene in the Moscow region. Genetika. 1997;3:1303–1307. [PubMed] [Google Scholar]
  • 8.Amosenko F.A., Sazonova M.A., Kapranov N.I., Trubnikova I.S., Kalinin V.N. Analysis of various polymorphic markers of the CFTR gene in cystic fibrosis patients and healthy donors from the Moscow region. Genetika. 1995;31:532–535. [PubMed] [Google Scholar]
  • 9.Amosenko F.A., Trubnikova I.S., Zakhar׳ev V.M., Bannikov V.M., Sazonova M.A., Petrova N.V., Kapranov N.I., Kalinin V.N. TUB9 polymorphism in the CFTR gene of cystic fibrosis patients, carriers, and healthy donors from the Moscow region. SSCP and restriction analyses. Genetika. 1997;33:257–261. [PubMed] [Google Scholar]
  • 10.Maniatis T., Sambrook J., Fritsch E.F. Cold Spring Harbor Laboratory; New York: 1982. Molecular Cloning: A Laboratory Manual; p. 545. [Google Scholar]
  • 11.Little P.F., Treisman R., Bierut L., Seed B., Maniatis T. Plasmid vectors for the rapid isolation and transcriptional analysis of human beta-globin gene alleles. Mol. Biol. Med. 1983;1:473–488. [PubMed] [Google Scholar]
  • 12.Andrews R.M., Kubacka I., Chinnery P.F., Lightowlers R.N., Turnbull D.M. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat. Genet. 1999;23:147. doi: 10.1038/13779. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary material

mmc1.doc (24.1KB, doc)

Supplementary material Table 1. Available data about subjects used in the study.

mmc2.xlsx (48.4KB, xlsx)

Articles from Data in Brief are provided here courtesy of Elsevier

RESOURCES